Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine: a running story on the front pages of 5 newsrooms from 17 April 2026 to 29 April 2026, 16 headlines over 13 days.

Follow this story on the globe Share

As it ran

29 April 2026

• AP FDA plans ultra-fast review of three psychedelic drugs following Trump directive

28 April 2026

• AP FDA plans ultra-fast review of three psychedelic drugs following Trump directive

27 April 2026

• AP FDA plans ultra-fast review of three psychedelic drugs following Trump directive

26 April 2026

• AP FDA plans ultra-fast review of three psychedelic drugs following Trump directive

25 April 2026

• AP FDA plans ultra-fast review of three psychedelic drugs following Trump directive
• AP Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

24 April 2026

• AP Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

22 April 2026

• AP Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

21 April 2026

• AP Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

20 April 2026

• AP Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
• Fox News Trump backs PSYCHEDELIC research

19 April 2026

• CNN Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’
• South China Morning Post Trump signs order to speed up review of psychedelics
• Al Jazeera Trump joined by Joe Rogan as he signs order to speed up psychedelic review
• AP Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

17 April 2026

• CNN Trump expected to sign executive order urging more research into psychedelic ibogaine